SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

Share Price is delayed by 15 minutes
Get Live Data
305.60    2.00 (0.66%)
Bid:
305.40
Ask:
306.00
Spread: 0.60 (0.196%)
Market Cap: £2.49b
ROR Live PriceLast checked at - London Stock Exchange

Intraday Rotork Share Chart

Share Buy-Back Programme

18 Aug 2021 07:00

RNS Number : 9502I
Rotork PLC
18 August 2021
 

Rotork Plc ("Rotork")

 

Share Buy-Back Programme

 

18 August 2021

 

As announced at the interim results on 3 August 2021, Rotork plc ('Rotork' or the 'Company') remains a highly cash generative business with a strong cash position that provides us with considerable financial flexibility. Consistent with our capital allocation policy, the Board has decided to return a prudent level of cash to shareholders while retaining a strong balance sheet. As a result, Rotork announces that it is commencing a share buyback programme (the 'Programme') to repurchase ordinary shares of 0.5 pence each in the capital of the Company ('Ordinary Shares'). The aggregate purchase price of all Ordinary Shares acquired under the Programme will be no more than £50 million (excluding stamp duty and expenses). Any Ordinary Shares purchased by the Company will be cancelled. This decision in no way reduces our appetite to pursue strategic investments and we remain active in looking for suitable opportunities.

 

The first tranche of the Programme will be carried out through an irrevocable non-discretionary agreement with J.P. Morgan Securities plc ('JPM'), pursuant to which JPM shall purchase Ordinary Shares as riskless principal (and not as agent of Rotork) for the subsequent sale on to, and purchase by, Rotork. The first tranche of the Programme will run from 19 August 2021 and end no later than 30 September 2021. The aggregate purchase price of all Ordinary Shares acquired under the first tranche of the Programme will be no greater than £20 million (excluding stamp duty and expenses). The maximum number of Ordinary Shares that can be purchased under the first tranche of the Programme is 8 million Ordinary Shares (based on authority granted at the Company's 2021 Annual General Meeting of 87.4 million Ordinary Shares). JPM will make its trading decisions in relation to the Ordinary Shares independently of, and uninfluenced by, the Company.

 

Any purchase of Ordinary Shares under the first tranche of the Programme will be carried out on the London Stock Exchange and any other UK recognised investment exchange which may be agreed, in accordance with pre-set parameters and in accordance with (and subject to limits prescribed by) the Company's general authority to repurchase Ordinary Shares granted by its shareholders at its 2021 Annual General Meeting, Chapter 12 of the Financial Conduct Authority's Listing Rules, Article 5(1) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018). Rotork will announce any market repurchases of Ordinary Shares no later than 7.30 a.m. on the business day following the calendar day on which the repurchase occurred.

 

 

Enquiries to:

 

Nick Hasell/Susanne Yule, FTI Consulting Tel: +44 (0) 203 727 1340

Andrew Carter, Investor Relations Director, Rotork Plc Tel: +44 (0) 1225 733 200

 

Notes:

Legal Entity Identity: 213800AH5RZIHGWRJ718

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSQDLFFFVLFBBX
Date   Source Headline
1st Feb 20234:00 pmRNSTotal Voting Rights
11th Jan 20234:00 pmRNSDirector/PDMR Shareholding
3rd Jan 202311:30 amRNSTotal Voting Rights
13th Dec 20224:00 pmRNSDirector/PDMR Shareholding
1st Dec 20222:00 pmRNSTotal Voting Rights
1st Dec 20227:00 amRNSAppointment of Chair Designate
25th Nov 20223:00 pmRNSHolding(s) in Company
23rd Nov 20227:00 amRNSTrading Update
17th Nov 20223:30 pmRNSHolding(s) in Company
16th Nov 20223:30 pmRNSHolding(s) in Company
11th Nov 20223:00 pmRNSDirector/PDMR Shareholding
4th Nov 20225:15 pmRNSHolding(s) in Company
3rd Nov 202211:00 amRNSHolding(s) in Company
2nd Nov 20227:00 amRNSCapital Markets Event
1st Nov 20223:30 pmRNSHolding(s) in Company
1st Nov 202211:00 amRNSTotal Voting Rights
31st Oct 20223:30 pmRNSHolding(s) in Company
28th Oct 20223:00 pmRNSHolding(s) in Company
25th Oct 20229:00 amRNSNear-term emissions targets approved by SBTi
17th Oct 20223:00 pmRNSHolding(s) in Company
13th Oct 20224:30 pmRNSHolding(s) in Company
13th Oct 20223:00 pmRNSHolding(s) in Company
12th Oct 20224:00 pmRNSDirector/PDMR Shareholding
12th Oct 20223:00 pmRNSHolding(s) in Company
11th Oct 20224:00 pmRNSDirector/PDMR Shareholding
5th Oct 20229:30 amRNS2022 AGM Voting Outcome Update Statement
3rd Oct 20225:45 pmRNSHolding(s) in Company
3rd Oct 20223:15 pmRNSTotal Voting Rights
15th Sep 202212:00 pmRNSDirector/PDMR Shareholding
14th Sep 202211:55 amRNSHolding(s) in Company
7th Sep 202211:00 amRNSHolding(s) in Company
1st Sep 202211:00 amRNSTotal Voting Rights
12th Aug 20223:30 pmRNSHolding(s) in Company
11th Aug 20223:30 pmRNSDirector/PDMR Shareholding
10th Aug 20224:45 pmRNSHolding(s) in Company
2nd Aug 20227:00 amRNS2022 Half Year Results
1st Aug 202211:00 amRNSTotal Voting Rights
18th Jul 20223:00 pmRNSHolding(s) in Company
15th Jul 20229:22 amRNSHolding(s) in Company
12th Jul 20225:22 pmRNSDirector/PDMR Shareholding
1st Jul 202212:00 pmRNSTotal Voting Rights
20th Jun 202210:30 amRNSPublication of 2021 Sustainability Report
6th Jun 20225:15 pmRNSDirector/PDMR Shareholding
1st Jun 202212:00 pmRNSTotal Voting Rights
30th May 202212:30 pmRNSDirector/PDMR Shareholding
17th May 20224:30 pmRNSHolding(s) in Company
17th May 20223:30 pmRNSDirector/PDMR Shareholding
12th May 202210:30 amRNSDirector/PDMR Shareholding
5th May 20223:30 pmRNSDirector/PDMR Shareholding
4th May 202210:15 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.